We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The once highly secretive Ribon Therapeutics has come out with a chunky series B with a focus on monoPARPs against cancer, inflammatory disorders and neurodegenerative diseases.....